NCT02415894已完成不适用
Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Ukraine
Gynuity Health Projects3 个研究点 分布在 1 个国家目标入组 172 人开始时间: 2015年4月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 172
- 试验地点
- 3
- 主要终点
- Rate of successful abortion
研究概览
简要总结
The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Ukraine.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Having an ongoing pregnancy of 13-22 weeks gestation
- •Be willing to undergo surgical completion if necessary
- •Have no contraindications to study procedures, according to provider
- •Be willing and able to consent to participate in the study
- •Be willing to follow study procedures
排除标准
- •Known allergy to mifepristone or misoprostol/prostaglandin
- •Any contraindications to vaginal delivery, including placenta previa
- •Unable to provide consent
结局指标
主要结局
Rate of successful abortion
时间窗: 15 hours after start of misoprostol induction
次要结局
未报告次要终点
研究者
研究点 (3)
Loading locations...
相似试验
已完成
不适用
Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in ArmeniaAbortion in Second TrimesterNCT01766388Gynuity Health Projects120
已完成
不适用
Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in UzbekistanAbortion in Second TrimesterNCT02235155Gynuity Health Projects135
Unknown
3 期
Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina FasoAbortion, Fetus MedicalNCT03269279Gynuity Health Projects100
终止
3 期
Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal DeathFetal DeathNCT02633761Gynuity Health Projects200
已完成
4 期
Mifepristone and Misoprostol for Fetal DemiseAnembryonic PregnancyGestation AbnormalityIntrauterine Fetal Demise TermNCT00177372University of Pittsburgh30